Induction Immunosuppressive Therapy Use in Deceased Donor Kidney Transplantation: 11-Year Experience in Veracruz, Mexico.

[1]  T. Srinivas,et al.  Prospective Randomized Controlled Trial of Rabbit Antithymocyte Globulin Compared With IL-2 Receptor Antagonist Induction Therapy in Kidney Transplantation , 2014, Annals of surgery.

[2]  A. Bagul,et al.  Thymoglobulin and Its Use in Renal Transplantation: A Review , 2013, American Journal of Nephrology.

[3]  G. S. Silva Júnior,et al.  Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin. , 2011, International immunopharmacology.

[4]  Spencer T. Martin,et al.  Induction Treatment with Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplant Recipients with Planned Early Steroid Withdrawal , 2011, Pharmacotherapy.

[5]  Ethan M Balk,et al.  KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. , 2010, Kidney international.

[6]  A. Webster,et al.  Interleukin 2 receptor antagonists for kidney transplant recipients. , 2010, The Cochrane database of systematic reviews.

[7]  J. Squifflet,et al.  Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. , 2009, Journal of the American Society of Nephrology : JASN.

[8]  M. Schnitzler,et al.  Early Outcomes of Thymoglobulin and Basiliximab Induction in Kidney Transplantation: Application of Statistical Approaches to Reduce Bias in Observational Comparisons , 2009, Transplantation.

[9]  D. Brennan,et al.  Rabbit antithymocyte globulin versus basiliximab in renal transplantation. , 2006, The New England journal of medicine.